Relx PLC
DUS:RDEB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Relx PLC
DUS:RDEB
|
UK |
|
C
|
CNH Industrial NV
F:37C
|
UK |
|
S
|
Stellantis NV
XMUN:8TI
|
NL |
|
A
|
Ascendis Pharma A/S
SWB:A71
|
DK |
|
S
|
STORE Capital Corp
F:S76
|
US |
|
C
|
CoStar Group Inc
XMUN:RLG
|
US |
|
S
|
SNP Schneider Neureither & Partner SE
F:SHF
|
DE |
Wall St Price Targets
RDEB Price Targets Summary
Relx PLC
According to Wall Street analysts, the average 1-year price target for RDEB is 42.71 EUR with a low forecast of 33.44 EUR and a high forecast of 64.19 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RDEB's stock price target?
Price Target
42.71
EUR
According to Wall Street analysts, the average 1-year price target for RDEB is 42.71 EUR with a low forecast of 33.44 EUR and a high forecast of 64.19 EUR.
What is the Revenue forecast for Relx PLC?
Projected CAGR
7%
Over the last 2 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 7 years is 7%.
What is the Operating Income forecast for Relx PLC?
Projected CAGR
12%
Over the last 2 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 3 years is 12%.
What is the Net Income forecast for Relx PLC?
Projected CAGR
16%
Over the last 2 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 4 years is 16%.
